Pelvic Cancer Registry for Online Adapted Radiotherapy

Recruiting Observational Study
Pelvic Tumor Thoracic Tumor
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
846 (estimated)
Sponsor
University Medical Center Goettingen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This prospective registry-based trial will include patients with pelvic or thoracic tumors with an indication for radiotherapy treated with oART or IGRT. For the primary endpoint and the secondary clinical endpoints, the trial will compare oART versus IGRT, for technical endpoints the trial will compare the real oART scenario with two virtual (hypothetical) control scenarios. Primary endpoint: *…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
INCLUSION CRITERIA * Patients with pelvic or thoracic tumors with an indication for radiotherapy * Patient information and declaration of consent * Patients age ≥ 18 years EXCLUSION CRITERIA * Prior radiotherapy in affected site
Contacts

Laura Anna Fischer

+49 551 3964501

laura-anna.fischer@med.uni-goettingen.de

CONTACT

Rami El Shafie

rami.elshafie@med.uni-goettingen.de

CONTACT